Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2004-4-29
pubmed:abstractText
Monte Carlo statistical mechanics simulations were used in combination with the extended linear response (ELR) approach to develop a model to predict the activities of kinase inhibitors. One hundred forty eight inhibitors of three protein kinases, cyclin-dependent kinase 2 (CDK2), lymphocyte-specific kinase (Lck), and p38 mitogen-activated protein kinase were considered. The inhibitor sets for the individual kinases were analyzed first, and ELR models using only three descriptors were obtained with correlation coefficients, r(2), of 0.7-0.8. Models for each pair of kinases were then developed and used to predict the activities of the inhibitors for the remaining kinase with resultant q(2) values of 0.71 (CDK2), 0.70 (Lck), and 0.54 (p38). Finally, the three datasets were combined to yield a general ELR model for kinase inhibition; with just three physically reasonable descriptors, EXX, DeltaHB(total), and DeltaSASA, the r(2) and leave-one-out q(2) are 0.69 and 0.67. The optimization of the model was confirmed using a genetic algorithm. The descriptors reflect the structural requirements for strong inhibition: good steric and electrostatic complementarities between inhibitor and protein, limited loss of hydrogen bonds for the inhibitor upon binding, and increased burial of surface area of the inhibitor.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/CDC2-CDC28 Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase 2, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Heterocyclic Compounds, 1-Ring, http://linkedlifedata.com/resource/pubmed/chemical/Heterocyclic Compounds, 2-Ring, http://linkedlifedata.com/resource/pubmed/chemical/Heterocyclic Compounds, 3-Ring, http://linkedlifedata.com/resource/pubmed/chemical/Ligands, http://linkedlifedata.com/resource/pubmed/chemical/Lymphocyte Specific Protein..., http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/p38 Mitogen-Activated Protein...
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-2623
pubmed:author
pubmed:issnType
Print
pubmed:day
6
pubmed:volume
47
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2534-49
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15115396-Algorithms, pubmed-meshheading:15115396-CDC2-CDC28 Kinases, pubmed-meshheading:15115396-Cyclin-Dependent Kinase 2, pubmed-meshheading:15115396-Enzyme Inhibitors, pubmed-meshheading:15115396-Heterocyclic Compounds, 1-Ring, pubmed-meshheading:15115396-Heterocyclic Compounds, 2-Ring, pubmed-meshheading:15115396-Heterocyclic Compounds, 3-Ring, pubmed-meshheading:15115396-Ligands, pubmed-meshheading:15115396-Lymphocyte Specific Protein Tyrosine Kinase p56(lck), pubmed-meshheading:15115396-Mitogen-Activated Protein Kinases, pubmed-meshheading:15115396-Models, Molecular, pubmed-meshheading:15115396-Monte Carlo Method, pubmed-meshheading:15115396-Protein Binding, pubmed-meshheading:15115396-Protein Conformation, pubmed-meshheading:15115396-Protein Kinase Inhibitors, pubmed-meshheading:15115396-Protein Kinases, pubmed-meshheading:15115396-Quantitative Structure-Activity Relationship, pubmed-meshheading:15115396-p38 Mitogen-Activated Protein Kinases
pubmed:year
2004
pubmed:articleTitle
General model for estimation of the inhibition of protein kinases using Monte Carlo simulations.
pubmed:affiliation
Department of Chemistry, Yale University, New Haven, Connecticut 06520-8107, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.